INS-19
Colony-stimulating factors are glycoproteins that act on bone marrow and certain cells in the blood to stimulate the development and growth of white blood cells.
INS-19 is a protein that binds to specific cell surface receptors and stimulates the production of disease fighting cells called neutrophils. It is used to treat certain medical conditions were a person's neutrophils are too low (neutropenia), such as in cancer patients who are receiving certain chemotherapeutic regimens, patients receiving bone marrow transplants, or in patients who have chronically low neutrophils for other reasons.
On April 16, 2008, Insmed announced the initiation of a clinical study for INS-19. Click here to read more.
